Advisory Council

Term ending October 31, 2018

Robert Discordia, Ph.D.
Vice President, Pharmaceutical Development & Manufacturing
Corbus Pharmaceuticals Inc.

William Fluharty
Business Director Americas-Chemical Manufacturing
Nexeo Solutions, LLC

Syed T. Husain
Chief Commercial Officer
Alcami Corporation

Scott Laird
Executive Director, Quality Assurance
Merck & Co., Inc.

Steve Poland
Global Director, 3rd Party FDF Technical Support
Mylan Inc.

Pam Tyler
Director of Sourcing
DPT, a Mylan Company

Term ending October 31, 2019

John Carney
Vice President, Pharmaceutical Specialties
Ashland

Robert Geiger
Vice President, Generic APIs
AmbioPharm, Inc.

Falguni Shah
Associate Vice President, Business Development & Global Pre-Sales
SAI Life Sciences Ltd.

Michael Trasatti
Vice President, PharmaProcessing Americas
MilliporeSigma

Term Ending October 31, 2020

Kelsey Achenbach
Head of Marketing, Pharmaceuticals
Roquette

Alessandra Barazza
Associate Director
Bristol-Myers Squibb

Elodie Cramer
Associate Director, Global Procurement
Biogen

Pauel Fokin
Regional Commercial Director
The Dow Chemical Company

Donna Gruol
Director, Business Development
Xellia Pharmaceuticals ApS

Vijay Ramanavarapu
President
Granules USA Inc.

Drug, Chemical & Associated
Technologies Association (DCAT)
One Union St., Suite 208
Robbinsville, NJ 08691
Phone: +1-609-208-1888
Toll free: +1-800-640-DCAT (3228)
Fax: +1-609-208-0599
info@dcat.org

The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. We are committed to provide programs, events and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting pharmaceutical development and manufacturing.